ABBOTT LABORATORIES — Director's Dealing 2018

Jul 26, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2018-07-25

Reporting Person: CAPEK JOHN M (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-07-25	Common shares without par value	M	64900	$26.0150	Acquired	363200	Direct
2018-07-25	Common shares without par value	S	64900	$65	Disposed	298300	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-07-25	Option (right to buy)	$26.015	M	64900	Disposed	2019-02-19	Common shares (64900)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.